Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
about
Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individualsEpoxyeicosatrienoic acids and cardioprotection: the road to translationSoluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single AgentEndothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heartCytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammationEpoxyeicosanoid signaling in CNS function and diseaseCYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) studyRole of soluble epoxide hydrolase in postischemic recovery of heart contractile functionRole of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injuryCharacterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.MALDI-TOF MS and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET).Structural and functional insights into polymorphic enzymes of cytochrome P450 2C8.The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of ChinaTargeting of splice variants of human cytochrome P450 2C8 (CYP2C8) to mitochondria and their role in arachidonic acid metabolism and respiratory dysfunction.Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian Patients.Diplotypes of CYP2C9 gene is associated with coronary artery disease in the Xinjiang Han population for women in China.Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.Relationship between CYP17A1 genetic polymorphism and coronary artery disease in a Chinese Han population.Cytochrome p450 enzymes and cardiovascular disease.Genetic polymorphisms of CYP2C8 in the Czech RepublicHuman CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liverCYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.Cytochrome p450 2C (CYP2C) in ischemic heart injury and vascular dysfunction.Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma.Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.Cytochrome P450 and ischemic heart disease: current concepts and future directions.Priority pharmacogenetics for the African continent: focus on CYP450.Cytochrome P450 and myocardial ischemia: potential pharmacological implication for cardioprotection.Identification of the Significant Involvement and Mechanistic Role of CYP3A4/5 in Clopidogrel BioactivationWarfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarctionCommon polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.CYP2C8 polymorphism among the Portuguese.Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids.Haplotype-based case-control study of CYP4A11 gene and myocardial infarction.Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism.Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.Combined effect of telmisartan and fluvastatin on arachidonic acid metabolism in human liver microsomes.Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients.The Role of CYP2C8 and CYP2C9 Genotypes in Losartan-Dependent Inhibition of Paclitaxel Metabolism in Human Liver Microsomes.Haplotype analyses of CYP17A1 genetic polymorphisms and coronary artery disease in a Uygur population.
P2860
Q28237144-248E330C-99F5-41FA-BCA1-9D46A77E46DBQ28241262-9884698A-31EB-4261-BD93-EE51F780D259Q28391163-303C9BDD-6DA2-4800-8E92-FDCBD5F584A6Q28392135-BF68E8FB-F29D-4F9A-A77D-9F9B1A4FB39AQ28393303-E4BE7BAF-7CA8-43E3-85E7-0A31652B2D7AQ28394441-8BDDE2DF-DE8F-43BB-AF3D-70EDC239250FQ28396513-A516101D-5E6B-4E82-99D1-D1846EB20455Q28397090-FE7E17DF-B1D6-435F-968D-097C1772FCC9Q28397180-894C2657-F39D-4976-AA95-A6F8763C54F1Q30939373-44A012CF-FA23-48D0-AC73-5E21C6754B20Q33211782-D2216CA5-7E74-4BD1-AF85-C7AB0FE62423Q33694471-5AD3003A-B1A3-42E5-9200-3CCF9054DA26Q34246447-8A755D79-D37A-4D28-8E9C-D7FAA901B330Q34396767-03BFF08D-D294-4265-BAA6-8AD20271ABBBQ34495642-467B64A4-9172-4DE4-BB86-E34B5D81D7E6Q34581729-438F6AA6-4CAA-4DB7-9924-FBD936CE6B74Q35039274-AFB347DF-C7B0-4DD5-9BFF-740281D6EFA3Q35176614-A3B17388-43E4-45A5-92B2-20DD89EA3747Q36006519-0C4432BB-7D5E-4FA9-AB89-F7CA2C924029Q36092754-16E9F24E-55D2-4E8C-B812-F9FA1058F761Q36174736-FC3913CD-25CA-4F07-A40F-E22578EB93C6Q36487403-582E8F09-5F76-4119-937B-6645F27F22FCQ36538334-C89C4E5C-9D30-49B3-851A-23FC60ABC82AQ37219846-13DCEB5C-193C-4C05-994C-8B89A42DCD0EQ37355303-24C100B1-EE63-41AF-A06B-595A37190F61Q38166022-7A3A5D75-C2F4-4C2B-9777-AADBFBC733CCQ38188600-A9AA911C-33DE-4676-A755-EF5B4D139D9BQ38225761-EAE550CD-2F90-42CB-8003-3554C019D804Q39540305-BB7650DB-1050-4386-8D7E-AB8F408962F4Q39591527-005B68D4-E0DB-4197-B29E-DF7CC9BC58E2Q43299072-70692AE4-23CF-4C00-8C49-175CA49F17D6Q45220471-3655DFE6-37FE-4190-986F-AE43F9B43206Q46730792-14272F6C-063B-496A-8F79-B47DA8B73F80Q46749490-8976F9E1-7CDC-4AD7-8029-158DB9196986Q46960269-F785D153-F266-4DCD-AA54-CE9B97E4680CQ48058245-AA51F4EA-1258-49B1-9413-5EEEAD613F25Q49967937-9E7FF457-7B90-445B-BD00-97062193998FQ50097447-CE446F32-8459-4745-AEFA-7F2D5C959DB6Q52903732-C5CB9C30-6EBD-44F6-854C-367B406BE653Q53636911-3D2F0C35-1260-494A-9717-835C887455DE
P2860
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
@en
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
@nl
type
label
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
@en
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
@nl
prefLabel
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
@en
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
@nl
P2093
P1476
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
@en
P2093
Anders Rane
Anna M Bennet
Björn Wiman
Stefan Lundgren
Ulf De Faire
Umit Yasar
P304
P356
10.1097/00008571-200312000-00002
P577
2003-12-01T00:00:00Z